SCHEMBL579118

SCHEMBL579118

[LiH].[N].[N]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL63757 1.00
SCHEMBL8602076 0.82
SCHEMBL11344229 0.82
SCHEMBL9245128 0.82
SCHEMBL9876840 0.82
SCHEMBL3125895 0.82
Hydrochloric Acid SCHEMBL11190191 0.82
SCHEMBL4342664 0.82
SCHEMBL1962877 0.71
SCHEMBL8434283 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115260074-A Preparation method of Paxlovid intermediate of oral antiviral drug 爱斯特(成都)生物制药股份有限公司 2022-11-01 CN claimed
EP-2767541-A1 LPA receptor agonists and antagonists Rxbio, Inc. (US) 2014-08-20 EP claimed
CN-115260074-A Preparation method of Paxlovid intermediate of oral antiviral drug 爱斯特(成都)生物制药股份有限公司 2022-11-01 CN disclosed
CN-115141184-A Ensaitevir preparation method 杭州国瑞生物科技有限公司 2022-10-04 CN disclosed
US-8735414-B2 Indole derivatives and methods for antiviral treatment PTC THERAPEUTICS, INC. (US) 2014-05-27 US disclosed
US-20120184574-A1 INDOLE DERIVATIVES AND METHODS FOR ANTIVIRAL TREATMENT PTC THERAPEUTICS, INC. (US) 2012-07-19 US disclosed
EP-2417122-A1 INDOLE DERIVATIVES AND METHODS FOR ANTIVIRAL TREATMENT PTC Therapeutics, Inc. (US) 2012-02-15 EP disclosed
WO-2010117932-A1 INDOLE DERIVATIVES AND METHODS FOR ANTIVIRAL TREATMENT SCHERING CORPORATION (US) 2010-10-14 WO disclosed
US-7276484-B2 Dipeptide inhibitors of β-secretase ELAN PHARMACEUTICALS, INC. (US) 2007-10-02 US disclosed
US-20050182138-A1 Dipeptide inhibitors of beta-secretase ELAN PHARMACEUTICALS, INC. 2005-08-18 US disclosed
US-6900331-B2 Derivatives of epothilone B and D and synthesis thereof UNIVERSITY OF NOTRE DAME (US) 2005-05-31 US disclosed
US-6864240-B1 Dipeptide inhibitors of β-secretase ELAN PHARMACEUTICALS, INC. (US) 2005-03-08 US disclosed
US-20030176473-A1 Derivatives of epothilone B and D and synthesis thereof TAYLOR RICHARD E (US) 2003-09-18 US disclosed
WO-2003074521-A1 DERIVATIVES OF EPOTHILONE B AND D AND SYNTHESIS THEREOF UNIVERSITY OF NOTRE DAME (US) 2003-09-12 WO disclosed
WO-2002046200-A1 MOCVD PRECURSORS BASED ON ORGANOMETALLOID LIGANDS RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2002-06-13 WO disclosed
US-6359159-B1 VAPOR DEPOSITION RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK 2002-03-19 US disclosed
US-6340768-B1 COMPOUNDS WITH SILICON, GERMANIUM, TIN AND LEAD WITH FLUOROCARBON COMPOUNDS RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK 2002-01-22 US disclosed
US-5284975-A Method of preparing α-d-phenylalkylbenzyl carbinol MALLINCKRODT SPECIALTY CHEMICALS COMPANY (US) 1994-02-08 US disclosed
US-4374292-A Process for preparing α-thujene LION CORPORATION (JP) 1983-02-15 US disclosed